Pharos Capital Group primarily invests $25 to $50 million in healthcare companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations. If you have an investment opportunity which you believe would be a fit for our firm, please reach out at info@pharosfunds.com.

Dallas, TX

3889 Maple Avenue, Suite 400

Dallas, TX 75219

Phone: (214) 855-0194

Fax: (214) 855-1230

Nashville, TN

5511 Virginia Way, Suite 180

Brentwood, TN 37027

Phone: (345) 234-5522

Fax: (345) 263-0234

Baltimore, MD

Phone: (410) 323-1105

Ben Chesnut

Vice President

About

Ben Chesnut is a Vice President at Pharos Capital Group. Mr. Chesnut is responsible for evaluating and executing investment opportunities, performing transaction due diligence, and working with management teams to implement operational and growth strategies.

Mr. Chesnut currently works with the firm's investments in Complete Health, Reel FX, Renal Care 360°, Sanderling Renal Services, and THEMA Health Services.

Prior to joining the firm in 2019, Mr. Chesnut was an Investment Banking Analyst at MHT Partners in Dallas, where he provided M&A transaction execution and advisory services to healthcare and business services companies. Previously, he was an Associate in KPMG’s Audit Practice, serving public clients in the Consumer and Industrial Business sector, and he worked for PTV Healthcare Capital, an Austin-based late-stage venture and growth capital firm focused on medical device and healthcare IT companies. Mr. Chesnut graduated with honors from the University of Texas at Austin with both a BBA and a Masters in Professional Accounting. Ben is based out of the firm’s Dallas office.